acrimony 发表于 2025-3-25 06:38:24

http://reply.papertrans.cn/2/123/12298/12298-21.png

visual-cortex 发表于 2025-3-25 08:12:36

http://reply.papertrans.cn/2/123/12298/12298-22.png

外向者 发表于 2025-3-25 13:43:00

http://reply.papertrans.cn/2/123/12298/12298-23.png

EXULT 发表于 2025-3-25 17:48:23

http://reply.papertrans.cn/2/123/12298/12298-24.png

micturition 发表于 2025-3-25 22:38:47

Submitted on: 10 May 2010.
Revised on: 29 June 2010.
Accepted on: 30 July 2010.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD

药物 发表于 2025-3-26 02:58:03

http://reply.papertrans.cn/2/123/12298/12298-26.png

QUAIL 发表于 2025-3-26 06:30:58

http://reply.papertrans.cn/2/123/12298/12298-27.png

充气女 发表于 2025-3-26 10:27:09

Submitted on: 16 September 2008.
Revised on: 06 January 2009.
Accepted on: 20 February 2009.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD

caldron 发表于 2025-3-26 14:06:02

Submitted on: 01 September 1999.
Revised on: 01 November 1999.
Accepted on: 21 November 1999.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD

Pathogen 发表于 2025-3-26 18:51:38

Submitted on: 22 July 2009.
Revised on: 23 October 2009.
Accepted on: 19 December 2009.

___________________ImmunoTargets and Therapy---DOVE MEDICAL PRESS LTD
页: 1 2 [3] 4
查看完整版本: ESCI期刊ImmunoTargets and Therapy 2024/2025影响因子:6.289 (IMMUNOTARGETS THER) (NULL). (IMMUNOLOGY)(免疫学)Emerging Sources Cita